PolettiV, PatelliM, PolettiG, BertantiT, SpigaL.Diffuse panbronchiolitis observed in an Italian (letter). Chest1990;98(2):515–516.
2.
RandhawaP, HoaglandMH, YousemSA. Diffuse panbronchiolitis in North America. Report of three cases and review of the literature. Am J Surg Pathol1991;15(1):43–47.
IwataM, ColbyTV, KitaichiM.Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations. Hum Pathol1994;25(4):357–363.
5.
HomerRJ, KhooL, SmithGJ. Diffuse panbronchiolitis in a Hispanic man with travel history to Japan. Chest1995;107(4):1176–1178.
6.
BazMA, KussinPS, Van TrigtP, DavisRD, RoggliVL, TapsonVF. Recurrence of diffuse panbronchiolitis after lung transplantation. Am J Respir Crit Care Med1995;151(3 Pt 1):895–898.
7.
FitzgeraldJE, KingTEJr, LynchDA, TuderRM, SchwarzMI. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med1996;154(2 Pt 1):497–503.
8.
CorneJ.Diffuse panbronchiolitis: a new Japanese export?Lancet1996;348(9040):1465–1466.
9.
HommaH, YamanakaA, TanimotoS, TamuraM, ChijimatsuY, KiraS, IzumiT.Diffuse panbronchiolitis; a disease of the transitional zone of the lung. Chest1983;83(1):63–69.
10.
SugiyamaY, KudohS, MaedaH, SuzakiH, TakakuF.Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis1990;141(6):1459–1462.
11.
TomitaY, HashimotoS, ShimizuT, SonK, AzumaA, KudohS, HorieT.Restriction fragment length polymorphism analysis in the HLA class III genes of patients with diffuse panbronchiolitis. Intern Med1996;35(9):693–697.
12.
KeichoN, TokunagaK, NakataK, TaguchiY, AzumaA, BannaiM, Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis. Am J Respir Crit Care Med1998;158(3):846–850.
KudohS, AzumaA, YamamotoM, IzumiT, AndoM.Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med1998;157(6 Pt 1):1829–1832.
15.
YamanakaA, SaikiS, TamuraS, SaitoK.[Problems in chronic obstructive bronchial diseases, with special reference to diffuse panbronchiolitis.]Naika1969;23(3):442–451.
16.
KimYW, HanSK, ShimYS, KimKY, HanYC, SeoJW, ImJG. The first report of diffuse panbronchiolitis in Korea: five case reports. Intern Med1992;31(5):695–701.
17.
TsangKW, OoiCG, IpMS, LamWK, NganH, ChanEY, Clinical profiles of Chinese patients with diffuse panbronchiolitis. Thorax1998;53(4):274–280.
18.
FisherMSJr, RushWL, Rosado-de-ChristensonML, GoldsteinER, TomskiSM, WempeJM, TravisWD. Diffuse panbronchiolitis: histologic diagnosis in unsuspected cases involving North American residents of Asian descent (review). Arch Pathol Lab Med1998;122(2):156–160.
19.
BrugiereO, MilleronB, AntoineM, CaretteMF, PhilippeC, MayaudC.Diffuse panbronchiolitis in an Asian immigrant. Thorax1996;51(10):1065–1067.
SugiyamaY, OhnoS, KanoS, MaedaH, KitamuraS.Diffuse panbronchiolitis and rheumatoid arthritis: a possible correlation with HLA-B54. Intern Med1994;33(10):612–614.
22.
HayakawaH, SatoA, ImokawaS, TodateA, ChidaK, SuzukiK, IwataM.Diffuse panbronchiolitis and rheumatoid arthritis-associated bronchiolar disease: similarities and differences. Intern Med1998;37(6):504–508.
23.
OnoK, ShimamotoY, MatsuzakiM, SanoM, YamaguchiT, KatoO, Diffuse panbronchiolitis as a pulmonary complication in patients with adult T-cell leukemia. Am J Hematol1989;30(2):86–90.
MatsuseT, FukuchiY, HsuCY, NagaseT, HigashimotoN, TeramotoS, Detection of human T lymphotropic virus type I proviral DNA in patients with diffuse panbronchiolitis. Respirology1996;1(2):139–144.
27.
KikuchiT, SaijoY, SakaiT, AbeT, OhnumaK, TezukaF, Human T-cell lymphotropic virus type I (HTLV-I) carrier with clinical manifestations characteristic of diffuse panbronchiolitis. Intern Med1996;35(4):305–309.
28.
KoyamaH, NishimuraK, MioT, IkedaA, SugiuraN, IzumiT.Bronchial responsiveness and acute bronchodilator response in chronic obstructive pulmonary disease and diffuse panbronchiolitis. Thorax1994;49(6):540–544.
29.
NodaY, YasuokaS, TaniK, OguraT, OgawaraM, KitataniF.Secretory IgA(S-IgA) levels in sera from patients with diffuse panbronchiolitis. Jpn J Med1989;28(2):189–195.
30.
NodaY, YasuokaS, InoueI, TaniK, FujisawaK, OguraT.Analysis of IgA antibody to Pseudomonas aeruginosa in sera and sputa of patients with chronic airway diseases. Intern Med1992;31(5):575–582.
31.
IchikawaY, KogaH, TanakaM, NakamuraM, TokunagaN, KajiM.Neutrophilia in bronchoalveolar lavage fluid of diffuse panbronchiolitis. Chest1990;98(4):917–923.
32.
OgushiF, TaniK, ManiwaK, IchikawaW, TadaH, KawanoT, SoneS.Interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis or idiopathic pulmonary fibrosis. J Med Invest1997;44(1-2):53–58.
33.
MukaeH, KadotaJ, KohnoS, KusanoS, MorikawaT, MatsukuraS, HaraK.Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med1995;152(2):613–618.
34.
KawakamiK, KadotaJ, IidaK, FujiiT, ShiraiR, MatsubaraY, KohnoS.Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis: the importance of cytotoxic T cells. Clin Exp Immunol1997;107(2):410–416.
35.
AquinoSL, GammsuG, WebbWR, KeeST. Tree-in-bud pattern: frequency and significance on thin section CT. J Comput Assist Tomogr1996;20(4):594–599.
36.
NishimuraK, KitaichiM, IzumiT, ItohH.Diffuse panbronchiolitis: correlation of high-resolution CT and pathologic findings. Radiology1992;184(3):779–785.
37.
IchikawaY, HottaM, SumitaS, FujimotoK, OizumiK.Reversible airway lesions in diffuse panbronchiolitis: detection by high-resolution computed tomography. Chest1995;107(1):120–125.
38.
TanimotoH.A review of the recent progress in treatment of patients with diffuse panbronchiolitis associated with Pseudomonas aeruginosa infection in Japan. Antibiot Chemother1991;44:94–98.
39.
KudohS, UetakeT, HagiwaraK, HirayamaM, HusLH, KimuraH, SugiyamaY.[Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis.]Nippon Kyobu Shikkan Gakkai Zasshi1987;25(6):632–642.
40.
NagaiH, ShishidoH, YonedaR, YamaguchiE, TamuraA, KurashimaA.Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration1991;58(3-4):145–149.
41.
SakataK, YajimaH, TanakaK, SakamotoY, YamamotoK, YoshidaA, DohiY.Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro. Am Rev Respir Dis1993;148(4 Pt 1):1061–1065.
42.
IchimiyaT, YamasakiT, NasuM.In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation. J Antimicrob Chemother1994;34(3):331–341.
43.
HáibyN.Diffuse panbronchiolitis and cystic fibrosis: East meets West (editorial). Thorax1994;49(6):531–532.
44.
BlackPN. Anti-inflammatory effects of macrolide antibiotics. Eur Respir J1997;10(5):971–972.
45.
YasuokaS, FujisawaK, UetaY, NiiY, InoueI, TaniK, Cell profile and elastase activity in diffuse panbronchiolitis investigated by bronchoalveolar and bronchial lavage. Intern Med1992;31(5):599–605.
46.
ImaiT, SasakiY, OhishiH, UchidaH, ItoS, MikasaK, Clinical aerosol inhalation cine-scintigraphy to evaluate mucociliary transport system in diffuse panbronchiolitis. J Nucl Med1995;36(8):1355–1362.
47.
FujiiT, KadotaJ, KawakamiK, IidaK, ShiraiR, KasedaM, Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax1995;50(12):1246–1252.
48.
IchikawaY, NinomiyaH, KogaH, TanakaM, KinoshitaM, TokunagaN, Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis1992;146(1):196–203.
49.
OdaH, KadotaJ, KohnoS, HaraK.Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis. Chest1994;106(4):1116–1123.
50.
SakitoO, KadotaJ, KohnoS, AbeK, ShiraiR, HaraK.Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration1996;63(1):42–48.
51.
OdaH, KadotaJ, KohnoS, HaraK.Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis. Chest1995;108(1):116–122.
52.
KadotaJ, SakitoO, KohnoS, SawaH, MukaeH, OdaH, A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis1993;147(1):153–159.
YasudaH, AjikiY, KogaT, KawadaH, YokotaT.Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother1993;37(9):1749–1755.
55.
YanagiharaK, TomonoK, SawaiT, HirakataY, KadotaJ, KogaH, Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. Am J Respir Crit Care Med1997;155(1):337–342.
56.
TamaokiJ, ChiyotaniA, TagayaE, SakaiN, KonnoK.Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis. Thorax1994;49(6):545–548.